Onctura has dosed the first subject in the open-label Phase II OCULE-01 trial of oral roginolisib in individuals with rare ...

As many as half of people diagnosed with uveal melanoma (ocular melanoma) go on to have what’s called metastatic disease. Most often, the cancer metastasizes (spreads) beyond the eye to the ...

After more than a decade studying a rare eye cancer that produces some of the hardest-to-fight tumors, researchers from University of Pittsburgh Medical Center have found a treatment that works on ...

The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...

Uveitis is a serious and sometimes painful eye condition that shouldn't be ignored. It's caused by inflammation in the uvea, a layer of tissue just inside the outer white part of your eye.

This inflammation can impact other parts of the body, too, including your eyes. The uvea is the eye layer most commonly impacted by inflammation from AS. It contains the pigmented part of your eye ...

including a doubling of overall survival compared to historical controls in rare eye cancer, uveal melanoma. The company has carefully designed its clinical program to allow full development in ...

After Green’s left eye was removed to prevent the spread of ... has not yet identified the potential cause, or causes, of uveal melanoma, and ADPH officials have stated it would be premature ...

and the first approved therapy for uveal melanoma – a form of cancer affecting the eye, according to Immunocore. Adding to that trio of firsts, Kimmtrak also got the green light from the FDA ...

L V Prasad Eye Institute highlights eye cancer is rare but serious threat that needs more awareness. Most people associate cancer with the lungs, breast, or skin, but few realize that cancer can also ...